Nasdaq Scheduled Resumption in Moleculin Biotech, Inc.
NEW YORK, May 27, 2020 (GLOBE NEWSWIRE) -- The Nasdaq Stock Market (Nasdaq: NDAQ) announced that trading in Moleculin Biotech, Inc. (Nasdaq: MBRX) is scheduled to resume on Thursday, May 28, 2020, at 7:00 a.m. Eastern Time. Trading in the company’s stock was halted on May 4, 2020 at 9:25:06 Eastern Time.
For news and additional information about the company, please contact the company directly or check under the company’s symbol using InfoQuotesSM on the Nasdaq Web site.
Anzeige
For more information about The Nasdaq Stock Market, visit the Nasdaq Web site at http://www.nasdaq.com.
NDAQO
Lesen Sie auch
Nasdaq Media Contact:
Bianca Fata
Bianca.Fata@nasdaq.com
Aktuelle Themen
Weitere Artikel des Autors
1 im Artikel enthaltener WertIm Artikel enthaltene Werte